$250M Settles TriCor Antitrust Class Suit V. Abbott

Law360 (April 24, 2009, 12:00 AM EDT) -- A federal judge has approved a $250 million settlement in the long-running antitrust class action that accused Abbott Laboratories and its French partner Fournier Industrie et Sante of conspiring to block generics makers from breaking into the lucrative market for the high-cholesterol drug TriCor.

The approval, granted Thursday by Judge Sue Robinson of the U.S. District Court for the District of Delaware, resolves the last of claims from the class of drug sellers.

The settlement includes class counsel fees that are 33.3 percent of the settlement fund — $83.3 million — and $3.6 million in costs.

The class counsel in the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!